Part 5 - Details and Expected Results for Other Expenses
Part 5.2 - Non-Departmental Other Expenses
Response to the Kiwifruit disease Pseudomonas syringae pv. actinidiae (M87)
Scope of Appropriation
This appropriation is limited to supporting an industry-led programme for the kiwifruit disease Pseudomonas syringae pv. actinidiae.
Reasons for Change in Appropriation
In November 2010, the Government approved $25 million in Crown funding, including MAF's direct response costs (excluding staff time), to support the kiwifruit industry-led programme for responding to the kiwifruit disease Pseudomonas syringae pv. actinidiae. A transfer of $2.500 million was made to departmental output expense Domestic Biosecurity Risk Management MCOA to cover MAF's direct response costs in 2010/11. The remaining $22.500 million is payable to the body established by industry "Kiwifruit Vine Health Inc" (KVH) as costs are incurred. In 2010/11 $11.228 million costs were incurred, and $11.272 million funding was transferred to 2011/12. An expense transfer of $1.500 million funding has been made to 2012/13.
